• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

“Weekend Warrior” physical activity patterns linked to lower mortality

byJames EnglandandAnees Daud
January 11, 2017
in Chronic Disease, Public Health
Reading Time: 3 mins read
Certain financial incentive programs may promote increased physical activity
Share on FacebookShare on TwitterShare on LinkedIn

1. In this analysis of questionnaire data from surveillance studies in England and Scotland, the pattern of physical activity consisting of one to two sessions per week (termed “Weekend Warriors”) was associated with reduced all-cause mortality.

2. Both weekend warrior and more regularly active participants demonstrated similar reductions in cardiovascular mortality. The former had a trend towards decreased cancer mortality, while the latter had significantly lower cancer mortality as compared with inactive participants.

Evidence Rating Level: 2 (Good)       

Study Rundown: A sedentary lifestyle remains an important modifiable risk factor for many life-limiting conditions. The World Health Organization (WHO) suggests minimum activity levels of 150 min/week of moderate exercise or 75 min/week of vigorous-intensity activity. Frequency of physical activity (spread over the course of the week versus in one or two sessions) within that one-week time has not been assessed. The current study used data from the Scottish Health Survey (SHS), and Health Survey of England (HSE) to assess differences in mortality between those who were sedentary, insufficiently active (one or two activity sessions but not meeting the WHO recommended activity time), weekend warriors (meeting WHO recommended activity time in one or two sessions), or regularly active.

Compared to those who were sedentary, insufficiently active, weekend warriors, and regularly active participants all demonstrated reduced all-cause and cardiovascular mortality. Weekend warriors also had a trend towards reduced cancer-specific mortality. The strengths of the study included the large sample size and attempted control for several confounding variables. The main limitations of the study included the reliance on questionnaire data, no determination for the reason for inactivity (unwell people may be less active), and no data on differences in injury patterns between the different activity strategies.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

An electronic health record tool for exercise prescription may reduce fall rate among older adults

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

Relevant Reading: The “Weekend Warrior” and Risk of Mortality

In-Depth [retrospective cohort]: This study used data from the HSE and SHS household surveillance studies from 1994 to 2008. Participants were included if they were 40 years or older and excluded if they died within 2 years of the start of study. Data on smoking habit, illness, occupation, ethnicity, BMI, dyslipidemia, and blood pressure was obtained and used for adjusted analysis. Mortality data was collected from the Nation Health Service Registry using standard codes for primary cause of death.

A total of 63 591 participants were included in the study with 62.8% classified as inactive (no moderate/vigorous activity reported), 22.4% were insufficiently active (less than 150 min/week moderate or 75 min/week vigorous activity), 3.7% were weekend warriors (sufficient exercise obtained in 1-2 sessions per week), and 11.1% were regularly active (3 or more sessions per week). Compared to those who were inactive, there was lower all-cause mortality for those who were insufficiently active (aHR 0.69; 95%CI 0.65-0.74), weekend warriors (aHR 0.70; 95%CI 0.60-0.82), and regularly active (0.65; 95%CI 0.58-0.73) participants. Results for cardiovascular mortality were similar with an adjusted HR of 0.63 (95%CI 0.55-0.72) for insufficiently active, 0.60 (95%CI 0.45-0.82) for weekend warriors, and 0.59 (95%CI 0.48-0.73) for regularly active participants. While regularly active participants had lower risk of cancer-related death (aHR 0.79; 95%CI 0.66-0.94), there was only a non-significant trend towards lower cancer mortality in weekend warriors (0.82; 95%CI 0.63-1.06).

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: exercisemortality
Previous Post

Breast cancer screening associated with substantial overdiagnosis in Danish study

Next Post

Tranexamic acid reduces bleeding risk during coronary artery surgery: The ATACAS trial

RelatedReports

An older woman looks thoughtfully to the side, with dumbbells, running shoes, and a bottle of supplements nearby, suggesting themes of exercise and health in geriatrics.
Chronic Disease

An electronic health record tool for exercise prescription may reduce fall rate among older adults

October 24, 2026
Collage of torn-gray map pieces with orange route from left to a doorway on the right, over a dark backdrop; scales of justice at top; '2 Minute Medicine' logo in bottom right.
Obstetrics

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

October 21, 2026
A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.
Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026
An older adult using a cane as he walks along a broken pathway, with images of a brain and EEG readings in the background, emphasizing mobility and neurological health.
Chronic Disease

Exercise and nutritional support reduce mobility disability in frail older adults

October 5, 2026
Next Post
High incidence of foreskin morbidity in uncircumcised males

Tranexamic acid reduces bleeding risk during coronary artery surgery: The ATACAS trial

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Radiolabeled somatostatin analogue linked with improved survival in neuroendocrine tumors

AAP recommends close monitoring of foster children by pediatricians

No difference between placebo, amitriptyline and topiramate in reducing pediatric migraine: The CHAMP trial

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.